A detailed history of Center For Financial Planning, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 14,742 shares of ABBV stock, worth $2.61 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
14,742
Previous 15,045 2.01%
Holding current value
$2.61 Million
Previous $2.58 Million 12.83%
% of portfolio
0.4%
Previous 0.37%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $49,643 - $60,396
-303 Reduced 2.01%
14,742 $2.91 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $16,562 - $19,341
107 Added 0.72%
15,045 $2.58 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $159,820 - $182,100
1,000 Added 7.17%
14,938 $2.72 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $10,320 - $11,622
75 Added 0.54%
13,938 $2.16 Million
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $3,206 - $3,711
24 Added 0.17%
13,863 $2.07 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $3,842 - $4,782
29 Added 0.21%
13,839 $1.86 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $62,037 - $71,445
-429 Reduced 3.01%
13,810 $2.2 Million
Q4 2022

Jan 27, 2023

SELL
$138.31 - $165.87 $7,053 - $8,459
-51 Reduced 0.36%
14,239 $0
Q3 2022

Oct 14, 2022

BUY
$134.21 - $153.93 $305,193 - $350,036
2,274 Added 18.92%
14,290 $1.92 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $1,289 - $1,631
12 Added 0.1%
12,016 $1.63 Million
Q3 2021

Oct 27, 2021

BUY
$106.4 - $120.78 $50,114 - $56,887
471 Added 4.08%
12,004 $1.3 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $67,313 - $74,103
658 Added 6.05%
11,533 $1.25 Million
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $12,900 - $19,558
200 Added 1.87%
10,875 $829,000
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $769,987 - $963,418
10,675 New
10,675 $945,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Center For Financial Planning, Inc. Portfolio

Follow Center For Financial Planning, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Center For Financial Planning, Inc. with notifications on news.